Form 4: UNITED THERAPEUTICS CEO Sells Shares
Insider Transaction (Form 4)
Martine A Rothblatt, Chairperson & CEO and a Director of UNITED THERAPEUTICS Corp, sold 9,500 shares of common stock on July 13, 2026.
Summary
- Option exercise/conversion: acquired 9,500 Common Stock at $135.42 ($1,286,490) on July 13, 2026; holds 50,013 after (Direct).
- Open-market sale: disposed of 1,020 Common Stock at $533.70 ($544,376) on July 13, 2026; holds 48,993 after (Direct).
- Open-market sale: disposed of 2,272 Common Stock at $534.63 ($1,214,669) on July 13, 2026; holds 46,721 after (Direct).
- Open-market sale: disposed of 2,191 Common Stock at $535.47 ($1,173,213) on July 13, 2026; holds 44,530 after (Direct).
- Open-market sale: disposed of 2,223 Common Stock at $536.52 ($1,192,674) on July 13, 2026; holds 42,307 after (Direct).
- Open-market sale: disposed of 665 Common Stock at $537.66 ($357,545) on July 13, 2026; holds 41,642 after (Direct).
- Open-market sale: disposed of 409 Common Stock at $538.60 ($220,289) on July 13, 2026; holds 41,233 after (Direct).
- Open-market sale: disposed of 320 Common Stock at $539.60 ($172,673) on July 13, 2026; holds 40,913 after (Direct).
- Open-market sale: disposed of 360 Common Stock at $541.10 ($194,796) on July 13, 2026; holds 40,553 after (Direct).
- Open-market sale: disposed of 40 Common Stock at $542.80 ($21,712) on July 13, 2026; holds 40,513 after (Direct).
- Option exercise/conversion: disposed of 9,500 Stock Option on July 13, 2026; holds 11,218 after (Direct).
Sentiment
Score: 4
Explanation: StockSavvy.ai views this as a mildly negative but low-conviction signal: an insider sold $5,091,949 of stock under a pre-arranged Rule 10b5-1 plan, which is typically routine.
Insider Transactions
Martine A Rothblatt — Director, Officer (Chairperson & CEO)
Transaction made under a Rule 10b5-1 trading plan.
| Date | Transaction | Security | Shares | Price | Value | Held After |
|---|---|---|---|---|---|---|
| 2026-07-13 | Option exercise/conversion | Common Stock | 9,500 | $135 | $1.3M | 50,013 |
| 2026-07-13 | Open-market sale | Common Stock | 1,020 | $534 | $544.4K | 48,993 |
| 2026-07-13 | Open-market sale | Common Stock | 2,272 | $535 | $1.2M | 46,721 |
| 2026-07-13 | Open-market sale | Common Stock | 2,191 | $535 | $1.2M | 44,530 |
| 2026-07-13 | Open-market sale | Common Stock | 2,223 | $537 | $1.2M | 42,307 |
| 2026-07-13 | Open-market sale | Common Stock | 665 | $538 | $357.5K | 41,642 |
| 2026-07-13 | Open-market sale | Common Stock | 409 | $539 | $220.3K | 41,233 |
| 2026-07-13 | Open-market sale | Common Stock | 320 | $540 | $172.7K | 40,913 |
| 2026-07-13 | Open-market sale | Common Stock | 360 | $541 | $194.8K | 40,553 |
| 2026-07-13 | Open-market sale | Common Stock | 40 | $543 | $21.7K | 40,513 |
| 2026-07-13 | Option exercise/conversion | Stock Option | 9,500 | — | — | 11,218 |
Key Dates
| Date | Description |
|---|---|
| 2026-07-13 | Option exercise/conversion (9,500 shares) |
| 2026-07-13 | Open-market sale (1,020 shares) |
| 2026-07-13 | Open-market sale (2,272 shares) |
| 2026-07-13 | Open-market sale (2,191 shares) |
| 2026-07-13 | Open-market sale (2,223 shares) |
| 2026-07-13 | Open-market sale (665 shares) |
| 2026-07-13 | Open-market sale (409 shares) |
| 2026-07-13 | Open-market sale (320 shares) |
| 2026-07-13 | Open-market sale (360 shares) |
| 2026-07-13 | Open-market sale (40 shares) |
| 2026-07-13 | Option exercise/conversion (9,500 shares) |
Keywords
insider transaction, Form 4, UTHR, UNITED THERAPEUTICS Corp, bearish, Martine A Rothblatt
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.